Inhibition of uterine contractility with various tocolytics with and without progesterone: In vitro studies

American Journal of Obstetrics and Gynecology

Volumn 206, Issue 3, 2012, Pages 254.e1-254.e5

  Baumbach, Jennifer ^b   Shi, Shao Qing ^a   Shi, Leili ^a   Balducci, James ^a   Coonrod, Dean V ^b   Garfield, Robert E ^a  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b MARICOPA MEDICAL CENTER   (United States)

Author keywords

preterm delivery; preterm labor; progesterone; tocolytics; uterine contractility

Indexed keywords

INDOMETACIN; MAGNESIUM SULFATE; NIFEDIPINE; PINACIDIL; PROGESTERONE; UTERUS SPASMOLYTIC AGENT;

ADULT; CESAREAN SECTION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UTERUS; UTERUS CONTRACTILITY;

EID: 84857781540     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2011.12.011     Document Type: Conference Paper

References (24)

1. R.L. Goldenberg The management of preterm labor Obstet Gynecol 100 2002 1020 1037
2. S. Beck, D. Wojdyla, L. Say et al. The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity Bulletin of the World Health Organization 88 2010 31 38
3. J.E. Lawn, S. Cousens, J. Zupan Lancet Neonatal Survival Steering Team 4 million neonatal deaths: when? where? why? Lancet 365 2005 891 900
4. J.A. Gazmararian, R. Petersen, D.J. Jamieson Hospitalizations during pregnancy among managed care enrollees Obstet Gynecol 100 2002 94 100
5. T.A. Bennett, M. Kotelchuck, C.E. Cox, M.J. Tucker, D.A. Nadeau Pregnancy-associated hospitalizations in the United States in 1991 and 1992: a comprehensive view of maternal morbidity Am J Obstet Gynecol 178 1998 346 354
6. B.M. Mercer, R.L. Goldenberg, A. Das The preterm prediction study: a clinical risk assessment Am J Obstet Gynecol 174 1996 1885 1895
7. E.R. Norwitz, J.N. Robinson, J.R. Challis The control of labor N Engl J Med 341 1999 660 666
8. J.D. Iams, R.L. Goldenberg, B.M. Mercer National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network The preterm prediction study: can low-risk women destined for spontaneous preterm birth be identified? Am J Obstet Gynecol 184 2001 652 655
9. K. Gyetvai, M.E. Hannah, E.D. Hodnett, A. Ohlsson Tocolytics for preterm labor: a systematic review Obstet Gynecol 94 1999 869 877
10. H.N. Simhan, S.N. Caritis Prevention of preterm delivery N Engl J Med 357 2007 477-67
11. R. Smith Parturition N Engl J Med 356 2007 271 283
12. A. Csapo Force of labor L. Iffy, H.A. Kaminetzky, Principles and practice of obstetrics and perinatology 1981 John Wiley and Sons Inc 7610 7699
13. American College of Obstetricians and Gynecologists Use of progesterone to reduce preterm birth: ACOG committee opinion no. 419 Obstet Gynecol 112 2008 963 965
14. E.B. Fonseca, E. Celik, M. Parra, M. Singh, K.H. Nicolaides Fetal Medicine Foundation Second Trimester Screening Group Progesterone and the risk of preterm birth among women with a short cervix N Engl J Med 357 2007 462 469
15. P.J. Meis, M. Klebanoff, E. Thom National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Prevention of recurrent preterm delivery by 17 alpha hydroxyprogesterone caproate N Engl J Med 348 2003 2379 2385
16. R.L. Goldenberg The management of preterm labor Obstet Gynecol 100 2002 1020 1037
17. E.B. da Fonseca, R.E. Bittar, M.H. Carvalho, M. Zugaib Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study Am J Obstet Gynecol 188 2003 419 424
18. S.S. Hassan, R. Romero, D. Vidyadhari PREGNANT Trial Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multi-center, randomized, double-blinded, placebo-controlled trial Ultrasound Obstet Gynecol 38 2011 18 31
19. M. Lucovnik, R.J. Kuon, L.R. Chambliss Progestin treatment for the prevention of preterm birth Acta Obstet Gynecol Scand 90 2011 1057 1069
20. R.J. Kuon, S.Q. Shi, H. Maul Pharmacologic actions of progestins to inhibit cervical ripening and prevent delivery depend on their properties, the route of administration, and the vehicle Am J Obstet Gynecol 202 2010 455.e1 455.e9
21. N.K. Ruddock, S.Q. Shi, S. Jain Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions Am J Obstet Gynecol 199 2008 391.e1 391.e7
22. T.A. Orth, S.Q. Shi, K. Williamson Additive inhibitory effects of progesterone and sodium nitroprusside on uterine contractility during pregnancy Reprod Sci 18 2011 868 875
23. J.W. Johnson, K.L. Austin, G.S. Jones, G.H. Davis, T.M. King Efficacy of 17-alpha-hydroxyprogesterone caproate in the prevention of premature labor N Engl J Med 293 1975 675 680
24. M.J. Keirse Progestogen administration in pregnancy may prevent preterm delivery Br J Obstet Gynaecol 97 1990 149 154